Effect of reduced dose of triptorelin at the start of ovarian stimulation on the outcome of IVF: A randomized study

Human Reproduction

Volumn 16, Issue 7, 2001, Pages 1409-1414

  Dal Prato, L ^a,b   Borini, A ^a   Trevisi, M R ^a   Bonu, M A ^a   Sereni, E ^a   Flamigni, C ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Tecnobios Procreazione   (Italy)

Author keywords

GnRH agonist; IVF; Ovarian stimulation; Reduced dose; Triptorelin

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; LUTEINIZING HORMONE; PROFASI HP; PROGESTERONE; TRIPTORELIN; UROFOLLITROPIN;

ABORTION; ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESENSITIZATION; DOSE RESPONSE; DRUG EFFECT; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; FOLLOW UP; HUMAN; HYPOPHYSIS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INFERTILITY; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; METABOLIC INHIBITION; NIDATION; OOCYTE MATURATION; OVARY FOLLICLE; OVULATION INDUCTION; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0034936990     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Pituitary-ovarian suppression by the standard and half-doses of D-Trp-6-luteinizing hormone-releasing hormone depot
2. The comparison of two gonadotrophin-releasing hormone agonists in an in-vitro fertilization program
3. Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization
4. Ovarian hyporesponsiveness in combined gonadotrophin-releasing hormone agonist and menotrophin therapy is associated with low serum follicle-stimulating hormone levels
5. Specific binding of gonadotrophin-releasing hormone and an agonist to human corpus luteum homogenates: Characterization, properties, and luteal phase levels
6. Short-term pituitary desensitization: Effects of different doses of the gonadotrophin-releasing hormone agonist triptorelin
7. Induction of luteolysis in the human with a long-acting analog of luteinizing hormone-releasing factor
8. Reducing the dose of gonadotrophin-releasing hormone agonist on starting ovarian stimulation: Effect on ovarian response and in-vitro fertilization outcome
9. Minidose gonadotrophin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels
10. Gonadotrophin-releasing hormone agonist dose-dependency of pituitary desensitization during controlled ovarian hyperstimulation in IVF
11. Dose-finding study of triptorelin acetate for prevention of a premature LH surge in IVF: A prospective, randomized, double-blind, placebo-controlled study
12. GnRH receptors in human granulosa cells: Anatomical localization and characterization by autoradiographic study
13. Use of a gonadotrophin-releasing hormone agonist during ovarian stimulation leads to significant concentrations of peptide in follicular fluids
14. A protocol using a low dose of gonadotrophin-releasing hormone agonist might be the best protocol for patients with high follicle-stimulating hormone concentrations on day 3
15. Effect of a luteinizing hormone-releasing hormone agonist (buserelin) on steroidogenesis of cultured human preovulatory granulosa cells
16. Comparison between depot and standard release triptoreline in in vitro fertilization: Pituitary sensitivity, luteal function, pregnancy outcome, and perinatal results
17. Comparison between depot leuprorelin and daily buserelin in IVF
18. A comparison between a standard and reduced dose of D-Trp-6-luteinizing hormone-releasing hormone administered after pituitary suppression for in-vitro fertilization
19. The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT
20. The use of gonadotrophin releasing hormone agonists for in-vitro fertilization and other assisted reproduction techniques: Experience from three centres
21. Inhibition of human granulosa cell progesterone secretion by a gonadotrophin-releasing hormone agonist
22. Never on a Sunday: Programming for IVF-ET and GIFT